April 21, 2026

How do universities move promising discoveries out of the lab and into the market? In this episode of BioTalk, Tatiana Litvin-Vechnyak, Vice President of Georgetown’s Office of Technology Commercialization, Christon Hill, Program Manager for Georgetown Tech Ventures, and Jennifer Butler, Entrepreneur-in-Residence with BioHealth Innovation, discuss how Georgetown is building a stronger pipeline from academic science to startup formation.

The conversation examines how Georgetown’s commercialization efforts are evolving, how GTV supports faculty founders, and why structured programming, outside expertise, and stronger ecosystem connections matter for turning research into real-world impact. 

BioHealth Capital Region Week will return on September 15 through 17, 2026, at US Pharmacopeia in Rockville, Maryland, bringing together leaders from industry, academia, government, and investment for three days focused on the future of one of the nation’s leading biohealth ecosystems. The event will again feature the BioHealth Capital Region Forum, the Crab Trap Competition, and the Investment Conference.

This year’s Forum theme, “Growing the BioHealth Capital Region of Tomorrow,” reflects both the region’s momentum and the need for continued collaboration at a time when many organizations are navigating a more uncertain funding environment. As public funding conditions shift, the region’s long-term strength will depend on its ability to deepen partnerships, support commercialization, attract investment, and build new pathways for growth. The Forum will serve as a place for those conversations to happen.

J.P. Morgan’s new Q1 2026 Biopharma Licensing and Venture Report shows a market that remains active, but more disciplined than in prior cycles. Venture funding slowed from last year’s pace, while licensing, M&A, and a modest rebound in IPO activity helped carry momentum into 2026. Across the market, investors and strategic buyers continue to favor later-stage assets, differentiated science, and programs with clearer clinical and commercial paths.

The report also points to strong licensing demand, milestone-heavy deal structures, continued interest in oncology and obesity-related programs, and a growing role for China-origin assets in major partnerships. For companies, investors, and ecosystem leaders, the message is clear: capital is still moving, but it is flowing toward programs that look more mature, more validated, and closer to value-inflection points.

THRiVE 2026 is bringing Virginia’s life sciences community together on April 30 in Richmond for a full day of conversation around innovation, investment, workforce, and growth across the bioscience sector. Hosted by Virginia Bio, the event will feature leaders from industry, government, research, and entrepreneurship, with sessions focused on startup momentum, funding in life sciences, workforce strategy, and the infrastructure needed to support long-term success.

With an opening reception on April 29 and a program designed to connect founders, executives, investors, and ecosystem partners, THRiVE 2026 is shaping up to be one of the state’s key gatherings for people working across biotech and health innovation. For anyone interested in where Virginia’s bioscience ecosystem is headed next, this is an event worth watching.

What does it take to build a biohealth ecosystem that can compete nationally? In this episode of BioTalk, Lisa Johnson, CEO of BioForward Wisconsin, discusses how Wisconsin helped shape the early use of the term “biohealth” and how that approach has supported the growth of its life sciences sector.



Lisa shares how BioForward connects industry, academia, and government to strengthen the state’s ecosystem, along with key developments that have brought increased attention to the region, including the expansion of Eli Lilly and Company. She also reflects on Wisconsin’s designation as a Biohealth Tech Hub through the U.S. Economic Development Administration and what it means for future growth.

COLUMBIA, Md., (April 15, 2026) — TEDCO, Maryland’s economic engine for technology companies, announced the next round of the Maryland Innovation Initiative (MII)’s Company Formation and Technology Assessment awardees, marking a significant milestone in promoting the commercialization of groundbreaking research from Maryland's prestigious academic research institutions.

“We continue to be awed with the innovative research taking place across Maryland’s research institutions and are excited to be awarding more than $2.1 million across 13 of these inspirational initiatives,” said Abi Kulshreshtha, executive director of TEDCO’s MII. “With these awards, we hope to see each one’s growth and, ultimately, the growth of Maryland’s innovation ecosystem.”

The Company Formation award is provided to support the efforts to commercialize technology licensed from Qualifying Universities.

ALBEMARLE COUNTY, Va. (CBS19 NEWS) -- Virginia Gov. Abigail Spanberger has signed legislation aimed at advancing a major pharmaceutical manufacturing facility planned for Albemarle County.

The measure, Senate Bill 527, provides financial incentives to AstraZeneca to support construction and operation of a new plant in northern Albemarle County. The bill was sponsored by Del. Amy Laufer and Sen. Creigh Deeds.

“I think it’s going to have a huge impact,” Deeds said. “At first, it’s going to create tax base for the county, which is going to be huge over the long haul. It’s going to create economic certainty.”

The legislation establishes a Pharmaceutical Substance Manufacturing Grant Fund, which could provide up to $34 million annually in incentives for up to 20 years. To qualify, a company must invest at least $4 billion in capital and create and maintain a minimum of 500 full-time jobs.

AURP Brings Industry Leaders to Manassas for Immersive Innovation Experience

The Association of University Research Parks (AURP) will host its Insights Into Research Parks program in Manassas, Virginia, on April 22–23, 2026, offering a hands-on look at the innovation ecosystem anchored by George Mason University.

This two-day experience is designed for thought leaders, economic developers, research park professionals, and university and industry partners seeking practical insight into how research-driven communities grow and succeed. Attendees will explore the infrastructure, partnerships, and culture that support research, commercialization, and regional economic development.

Participants will gain direct exposure to the Innovation District surrounding George Mason University’s Science...

USP (U.S. Pharmacopeia) is pleased to host an upcoming public event, Advancing U.S. Health Security: Scaling Innovative Solutions for Medicines Supply Chain Resiliency, where we will evaluate levers and scalable, innovative solutions that build a more resilient pharmaceutical supply chain.

Building on USP’s recent launch of the USP Resiliency Center, where we grounded our understanding of the U.S. medicine supply chain in end-to-end data and visibility, our speakers and panelists will discuss next steps to solve challenges and scale solutions for U.S. medicine supply chain resiliency.

The event will be hosted in-person at USP’s Rockville office, with the option to attend virtually as well. Breakfast and lunch will be provided for in-person attendees.

By Sara Gilgore – Staff Reporter, Washington Business Journal

Apr 16, 2026 - The Montgomery County Economic Development Corp. has hired a new vice president of business development, the second key position its new CEO has filled in recent weeks.

The organization said Thursday that Danny Chavez, a longtime economic development executive and entrepreneur, will assume the role May 4.

The position has been vacant since mid-2024.

Chavez brings a dozen years of experience in economic development, currently as co-founder and chief operating officer of San Antonio, Texas-based Incenti Solutions Inc., a 1-year-old company with an artificial intelligence-based operating system for economic development organizations. (Subscription Required)

FOSTER CITY, Calif.--(BUSINESS WIRE)-- Gilead Sciences, Inc. (Nasdaq: GILD) announced today that all required regulatory approvals have been obtained for its previously announced acquisition of Arcellx and that Gilead has extended the expiration of the tender offer to purchase all outstanding shares of common stock of Arcellx.

On April 13, 2026, the Australian Competition and Consumer Commission (ACCC) published its decision that the acquisition of Arcellx may be put into effect, subject to expiration of a 14-calendar day waiting period. Assuming that the ACCC’s determination remains unchallenged during this waiting period, the waiting period expires at 10:00 a.m., Eastern Time, on April 27, 2026. Additionally, the relevant review period for the Austrian competition authorities has expired. Accordingly, all required regulatory approvals for the transaction have been obtained, and the “Regulatory Approvals Condition” (as defined in the Offer to Purchase, dated March 6, 2026, relating to the offer) will be satisfied upon expiration of the 14-calendar day review period pursuant to Australian competition law.

The Baltimore Health Tech Startup Symposium will take place on May 1, 2026, from 9:30 to 11:30 a.m. at The Garage at R. House in Baltimore. Hosted by the NSF I-Corps Hub Mid-Atlantic Region, the event will bring together founders, researchers, investors, biotech leaders, and ecosystem builders for a morning centered on the growth and potential of Baltimore’s health tech community. Attendees will gain insight into what it takes to move promising ideas into the marketplace and why Maryland continues to stand out as a strong environment for health tech innovation.

The program will include opening remarks from a leader in clinical innovation at Johns Hopkins Health System, followed by a panel discussion on launching a health tech company in Maryland. Designed for those building startups, supporting research commercialization, exploring investment opportunities, or seeking meaningful connections in the field, the symposium offers a valuable opportunity to learn from experienced voices and engage with the region’s health tech ecosystem.